Assessment of compliance with recommendations for HIV perinatal transmission prevention, timely diagnosis and early treatment of children living with HIV in Brazil.

IF 2.8 3区 医学 Q2 INFECTIOUS DISEASES
HIV Medicine Pub Date : 2025-05-06 DOI:10.1111/hiv.70038
Alexandre Alberto Cunha Mendes-Ferreira, Andrea Mônica Brandão Beber, Lino Neves da Silveira, Aranaí S D Guarabyra, Isabela Ornelas Pereira, Nazle Mendonça Collaço Véras, Rosana Elisa Gonçalves Gonçalves Pinho, Ana Roberta Pascom, Angelica Espinosa Miranda, Vivian I Avelino-Silva
{"title":"Assessment of compliance with recommendations for HIV perinatal transmission prevention, timely diagnosis and early treatment of children living with HIV in Brazil.","authors":"Alexandre Alberto Cunha Mendes-Ferreira, Andrea Mônica Brandão Beber, Lino Neves da Silveira, Aranaí S D Guarabyra, Isabela Ornelas Pereira, Nazle Mendonça Collaço Véras, Rosana Elisa Gonçalves Gonçalves Pinho, Ana Roberta Pascom, Angelica Espinosa Miranda, Vivian I Avelino-Silva","doi":"10.1111/hiv.70038","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Strategies for perinatally transmitted HIV (PTHIV) prevention are inconsistently adopted. Moreover, delays in diagnosis and treatment initiation for children living with HIV may aggravate outcomes.</p><p><strong>Methods: </strong>We used a survey study administered to Brazilian maternities to evaluate compliance with individual PTHIV prevention interventions as well as the overall compliance using a combined endpoint. We also investigated associations with the average number of births per month and municipal social vulnerability index (SVI) using regression models. Next, using data from Brazilian HIV monitoring systems, we obtained information on age at first HIV viral load (VL) testing and age at first antiretroviral dispensation to evaluate delayed diagnosis (first VL testing ≥6 months) and delayed antiretroviral initiation (first dispensation ≥12 months) among children living with HIV, investigating associations with race/ethnicity, sex and SVI.</p><p><strong>Results: </strong>Of 801 maternities, only 21% were compliant with the combined endpoint. Facilities located in cities with higher SVI and those with a lower number of births per month had lower odds of being compliant. Among 1152 children living with HIV, the median age at first HIV VL testing was 3 months (range 0-18) and 24% had a delayed diagnosis. Children living with HIV in cities with higher SVI had higher odds of delayed diagnosis. The median age at antiretroviral initiation was 6 months (range 1-120), and those with a delayed diagnosis had higher odds of delayed treatment initiation (aOR 4.9, 95% CI 3.5-9.9).</p><p><strong>Conclusion: </strong>Our study reveals significant challenges in access to PTHIV prevention, timely diagnosis and timely treatment initiation for children living with HIV, potentially related to social determinants.</p>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/hiv.70038","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Strategies for perinatally transmitted HIV (PTHIV) prevention are inconsistently adopted. Moreover, delays in diagnosis and treatment initiation for children living with HIV may aggravate outcomes.

Methods: We used a survey study administered to Brazilian maternities to evaluate compliance with individual PTHIV prevention interventions as well as the overall compliance using a combined endpoint. We also investigated associations with the average number of births per month and municipal social vulnerability index (SVI) using regression models. Next, using data from Brazilian HIV monitoring systems, we obtained information on age at first HIV viral load (VL) testing and age at first antiretroviral dispensation to evaluate delayed diagnosis (first VL testing ≥6 months) and delayed antiretroviral initiation (first dispensation ≥12 months) among children living with HIV, investigating associations with race/ethnicity, sex and SVI.

Results: Of 801 maternities, only 21% were compliant with the combined endpoint. Facilities located in cities with higher SVI and those with a lower number of births per month had lower odds of being compliant. Among 1152 children living with HIV, the median age at first HIV VL testing was 3 months (range 0-18) and 24% had a delayed diagnosis. Children living with HIV in cities with higher SVI had higher odds of delayed diagnosis. The median age at antiretroviral initiation was 6 months (range 1-120), and those with a delayed diagnosis had higher odds of delayed treatment initiation (aOR 4.9, 95% CI 3.5-9.9).

Conclusion: Our study reveals significant challenges in access to PTHIV prevention, timely diagnosis and timely treatment initiation for children living with HIV, potentially related to social determinants.

评估巴西关于预防艾滋病毒围产期传播、及时诊断和早期治疗感染艾滋病毒儿童的建议的执行情况。
前言:围产期传播艾滋病毒(phiv)预防策略的采用不一致。此外,对感染艾滋病毒的儿童进行诊断和开始治疗的延误可能会加重结果。方法:我们对巴西产妇进行了一项调查研究,以评估个体phiv预防干预措施的依从性以及使用联合终点的总体依从性。我们还使用回归模型调查了每月平均出生人数和城市社会脆弱性指数(SVI)之间的关系。接下来,利用巴西艾滋病毒监测系统的数据,我们获得了首次接受艾滋病毒载量(VL)检测的年龄和首次接受抗逆转录病毒治疗的年龄信息,以评估感染艾滋病毒的儿童的延迟诊断(首次VL检测≥6个月)和延迟开始抗逆转录病毒治疗(首次接受抗逆转录病毒治疗≥12个月),调查与种族/民族、性别和SVI的关系。结果:801名产妇中,只有21%符合联合终点。位于SVI较高的城市和每月出生人数较低的城市的设施遵守规定的几率较低。在1152名感染艾滋病毒的儿童中,首次进行艾滋病毒VL检测的中位年龄为3个月(范围0-18岁),24%的儿童诊断延迟。在SVI较高的城市中,感染艾滋病毒的儿童延迟诊断的几率较高。开始抗逆转录病毒治疗的中位年龄为6个月(范围1-120),延迟诊断的患者延迟开始治疗的几率更高(aOR为4.9,95% CI为3.5-9.9)。结论:我们的研究揭示了感染艾滋病毒的儿童在获得预防、及时诊断和及时治疗方面面临的重大挑战,这可能与社会决定因素有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
HIV Medicine
HIV Medicine 医学-传染病学
CiteScore
5.10
自引率
10.00%
发文量
167
审稿时长
6-12 weeks
期刊介绍: HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信